摘要
背景:在血液,间质液,胃肠液,眼泪等体液中含有较多浓度的阳离子和阴离子。离子反应药物递送可用于设计独特的剂量制剂,其提供优化的药物治疗,有效,安全和方便地给予药物。 目标:本次审查的目的是收集,总结和分类关于离子响应给药系统的最新研究成果。 结果:体液/制剂中的离子引起制剂中所含聚合物/分子的结构变化,使制剂显示出功能。对离子响应的聚合物/分子是离子交换树脂/纤维,阴离子或阳离子聚合物,在较低临界溶液温度下表现出过渡的聚合物,自组装超分子体系,肽和金属有机骨架。离子响应药物递送系统的功能被分类为受控药物释放,位点特异性药物释放,原位凝胶化,在目标位点长期保留以及增强药物渗透。通过口服,眼用,透皮和鼻用途径给药制剂在最近的文献中显示出显着的优点。 结论:最近有多种给药途径报道了多种对离子有响应的给药系统。这些系统的改进和进步可以最大限度地发挥药物潜力,并为世界各地的患者做出贡献
关键词: 离子响应药物递送系统,离子交换络合物,较低临界溶解温度,受控药物释放,盐析效应,掩味,原位凝胶化,眼睛延长保留。
图形摘要
Current Drug Targets
Title:Ion-Responsive Drug Delivery Systems
Volume: 19 Issue: 3
关键词: 离子响应药物递送系统,离子交换络合物,较低临界溶解温度,受控药物释放,盐析效应,掩味,原位凝胶化,眼睛延长保留。
摘要: Background: Some kinds of cations and anions are contained in body fluids such as blood, interstitial fluid, gastrointestinal juice, and tears at relatively high concentration. Ionresponsive drug delivery is available to design the unique dosage formulations which provide optimized drug therapy with effective, safe and convenient dosing of drugs.
Objective: The objective of the present review was to collect, summarize, and categorize recent research findings on ion-responsive drug delivery systems.
Results: Ions in body fluid/formulations caused structural changes of polymers/molecules contained in the formulations, allow formulations exhibit functions. The polymers/molecules responding to ions were ion-exchange resins/fibers, anionic or cationic polymers, polymers exhibiting transition at lower critical solution temperature, self-assemble supramolecular systems, peptides, and metalorganic frameworks. The functions of ion-responsive drug delivery systems were categorized to controlled drug release, site-specific drug release, in situ gelation, prolonged retention at the target sites, and enhancement of drug permeation. Administration of the formulations via oral, ophthalmic, transdermal, and nasal routes has showed significant advantages in the recent literatures.
Conclusion: Many kinds of drug delivery systems responding to ions have been reported recently for several administration routes. Improvement and advancement of these systems can maximize drugs potential and contribute to patients in the world.
Export Options
About this article
Cite this article as:
Ion-Responsive Drug Delivery Systems, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160527142138
DOI https://dx.doi.org/10.2174/1389450117666160527142138 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews The Assessment of Cryopreservation Conditions for Human Umbilical Cord Stroma-Derived Mesenchymal Stem Cells towards a Potential Use for Stem Cell Banking
Current Stem Cell Research & Therapy Role of α -Crystallin B in Regulation of Stress Induced Cardiomyocyte Apoptosis
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Simulation to Train Gynecology Residents in Minimally Invasive Surgery
Current Women`s Health Reviews Pharmacology of TRP Channels in the Vasculature
Current Vascular Pharmacology α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Current Pharmaceutical Design Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Recent Patents on Cardiovascular Drug Discovery Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Current Alzheimer Research Battle for Pluripotency: Derivation of Induced Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Strategies for Novel Therapeutic Approaches Targeting Cytokines and Signaling Pathways of Osteoclasto- and Osteoblastogenesis in the Fight Against Immune-Mediated Bone and Joint Diseases
Current Medicinal Chemistry Fluorescence Polarization Immunoassays for Metal Ions
Combinatorial Chemistry & High Throughput Screening Role of Nitrosative Stress and Poly(ADP-ribose) Polymerase Activation in Diabetic Vascular Dysfunction
Current Vascular Pharmacology First Inhibitors of the Steroidogenic Enzyme Type 7 17β-Hydroxysteroid Dehydrogenase
Letters in Drug Design & Discovery Killer Beacons for Combined Cancer Imaging and Therapy
Current Medicinal Chemistry Synthesis and Applications of Hydrogels in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Role of Matrix Metalloproteinases in Animal Models of Ischemic Stroke
Current Vascular Pharmacology Editorial (Thematic Issue: Contemporary siRNA Therapeutics and the Current State-of-Art)
Current Pharmaceutical Design Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets